PXL/HO/Cir-067/2022-23                                                                            Date: 06.12.2022

Hyderabad

Subject: Pharmexcil Business Delegation to Oceania (Australia & New Zealand) during 18th - 25th January 2023 (MAI assistance available).

We are pleased to inform that Pharmexcil with the support of the Ministry of Commerce & Industry, Government of India is organizing Business Delegation to Oceania (Australia & New Zealand) during the second half of January commencing from 18th Jan 2023 until 25th Jan 2023.

You are kindly aware that Pharmexcil endeavors to explore opportunities for its member companies in global markets through various trade promotion activities. While we continue to focus on semi-regulated markets, the significance of regulated and highly evolved markets cannot be lost out as they are high value markets and adds immense credibility to Brand India Pharma.

Oceania region is one of the emerging markets & Indian pharma Exports to the region amounted to USD 466.21 million during FY 2022 with a growth rate of 8.9 %. Furthermore, the growing demand for Indian generics is remarkably noted during the last fiscal year. The recently ratified India – Australia ECTA given a much-needed spark to enhance and scale new heights of bilateral trade engagements especially in the Pharma sector as the TGA, Australia has agreed for fast track approval for patented, generic and biosimilar medicines using the Comparable Overseas Regulator Pathway.These are expected to be a significant trade facilitation measure for India's pharma sector which will enable Indian Pharma companies to access the Australian market and aid in boosting India’s pharma exports.

The tentative program schedule proposed for the delegation as below: 

 (The final dates are subject to confirmation from our respective missions and may change, as required)

Pharmexcil is planning to host the potential Business delegates from other pacific islands (Fiji, Papua New Guinea etc) at Auckland/Sydney and arrange meetings with Indian delegation.

Participation Details:

Participation Fee(Non-Refundable): Rs. 75,000/- per company

Participation fee includes BSM set up at all Destinations, local transfers wherever required for Government meetings, Regulatory meetings etc. The amount is refunded only if the event is canceled due to unavoidable circumstances at the instance of our Mission/Council.

Registration:  Members are requested to submit the mandatory Registration form https://forms.gle/M45xsBWgsrFJLQ6CA

Post submission of the Registration form, you are required to pay the participation fee ofINR 75,000/- in favor of “Pharmaceuticals Export Promotion Council of India” and share the payment details with accounts2@pharmexcil.com. (Bank details enclosed).

Timeline: Deadline for payment is 16^th Dec 2022. Members may please note that confirmation of your participation is based on receipt of the payment only.

Travel & Logistics: The suggested Flight itinerary, Hotel names and tariffs (in consultation with Indian Missions abroad) will be communicated in due course. Member companies are required to secure their business visas and make their reservations directly. The council will arrange required visa invitations from destination countries and issue visa recommendation letters for the participating Indian delegates.

MAI ASSISTANCE: Members whose export turnover during previous year are less than Rs.50.00 crores and are having minimum of one year (12 calendar months) membership with the council are eligible for MAI assistance subject to the other guidelines of MAI scheme. Under the scheme Director/Partner/Proprietor/Senior Managers can avail reimbursement of economy class airfare subject to a maximum of INR 75,000/- per company.

 Note:

Ø  Participation to both destinations is mandatory to claim MAI assistance.

Ø  Destination can undergo change/modifications/canceled subject to our Embassy/Missions advice in view of unavoidable circumstances.

For any further clarifications, members may contact us at romumbai@pharmexcil.com with a copy to regulatory@pharmexcil.com, (Ph.No: 98208 89583, 022-28200593/94)

Looking forward to your participation.

Thanking you,

 With regards,

Udaya Bhaskar

Director General

Bank details : The payment may be made by NEFT/RTGS as per details below:

Beneficiary name : Pharmaceuticals Export Promotion Council of India

Bank Name          : Union Bank of India

Current A/c. No    :  510131000001693

IFSC Code            :  UBIN0805220